|
Category: humectants, solvents
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | colorless to pale yellow clear oily liquid (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Specific Gravity: | 1.11300 @ 25.00 °C.
|
| Melting Point: | -12.00 to -11.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 197.00 to 198.00 °C. @ 760.00 mm Hg
|
| Boiling Point: | 121.00 to 122.00 °C. @ 50.00 mm Hg
|
| Vapor Pressure: | 0.096000 mmHg @ 25.00 °C. (est) |
| Flash Point: | > 230.00 °F. TCC ( > 110.00 °C. )
|
| logP (o/w): | -1.688 (est) |
| Soluble in: |
| | water, 1e+006 mg/L @ 25 °C (est) |
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
| AquaChemie |
| For experimental / research use only. |
| Mono EthyleneGlycol - MEG
|
| BASF |
| Ethylene Glycol
|
| BOC Sciences |
| For experimental / research use only. |
| Ethylene glycol 99%
|
| Covalent Chemical |
| Ethylene Glycol
|
| ECSA Chemicals |
| ETHYLENE GLYCOL 30%
|
| ECSA TRADE THE MOST UPDATED FINANCIAL PUBLICATION ON THE WORLD OF CHEMISTRY |
| ECSA Chemicals |
| ETHYLENE GLYCOL RE-PURE, ML 1000
|
| ECSA Chemicals |
| ETHYLENE GLYCOL
|
| EMD Millipore |
| For experimental / research use only. |
| Ethylene Glycol
|
| Glentham Life Sciences |
| Ethylene glycol
|
| Graham Chemical |
| Ethylene Glycol
|
| Krunal Group |
| Mono Ethylene Glycol (MEG)
|
| Lluch Essence |
| ETHYLENE GLYCOL
|
| LyondellBasell Industries |
| Ethylene glycols
|
| Sigma-Aldrich |
| For experimental / research use only. |
| Ethylene glycol anhydrous, 99.8%
|
| Silver Fern Chemical |
| Ethylene Glycol, Inhibited – FernTherm
Odor: characteristic Use: Applications for FernTherm-EG Inhibited include closed loop heating and cooling systems, solar heating, thermal energy storage, sidewalk subsurface heating, refrigeration warehouse floor heating, ice rinks, freeze and burst protection in semi-sedentary systems, various deicing functions, cold room dehumidifying, and more. |
| Wedor Corporation |
| ETHYLENE GLYCOL
|
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
oral-cat LD50 1650 mg/kg KIDNEY, URETER, AND BLADDER: OTHER CHANGES Recueil de Medecine Veterinaire. Vol. 154, Pg. 137, 1978.
oral-child TDLo 5500 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
BEHAVIORAL: GENERAL ANESTHETIC
KIDNEY, URETER, AND BLADDER: OTHER CHANGES Postgraduate Medical Journal. Vol. 52, Pg. 598, 1976.
oral-dog LD50 5500 mg/kg KIDNEY, URETER, AND BLADDER: OTHER CHANGES Recueil de Medecine Veterinaire. Vol. 154, Pg. 137, 1978.
oral-guinea pig LD50 6610 mg/kg GASTROINTESTINAL: OTHER CHANGES
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Journal of Industrial Hygiene and Toxicology. Vol. 23, Pg. 259, 1941.
unreported-guinea pig LD50 11150 mg/kg BEHAVIORAL: EXCITEMENT
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
GASTROINTESTINAL: NAUSEA OR VOMITING Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 33(3), Pg. 16, 1968.
oral-human LDLo 398 mg/kg GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: HEADACHE
LIVER: OTHER CHANGES Sudebno-Meditsinskaya Ekspertiza. Forensic Medical Examination. Vol. 26(2), Pg. 48, 1983.
oral-human LDLo 786 mg/kg GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
BEHAVIORAL: COMA
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD European Journal of Toxicology and Environmental Hygiene. Vol. 9, Pg. 373, 1976.
unreported-man LDLo 1637 mg/kg "Poisoning; Toxicology, Symptoms, Treatments," 2nd ed., Arena, J.M., Springfield, IL, C.C. Thomas, 1970Vol. 2, Pg. 73, 1970.
oral-man TDLo 1195 mg/kg KIDNEY, URETER, AND BLADDER: RENAL FUNCTION TESTS DEPRESSED
PERIPHERAL NERVE AND SENSATION: SENSORY CHANGE INVOLVING PERIPHERAL NERVE Annals of Emergency Medicine. Vol. 20, Pg. 208, 1991.
oral-man TDLo 15000 mg/kg KIDNEY, URETER, AND BLADDER: RENAL FUNCTION TESTS DEPRESSED
PERIPHERAL NERVE AND SENSATION: SENSORY CHANGE INVOLVING PERIPHERAL NERVE
GASTROINTESTINAL: ULCERATION OR BLEEDING FROM SMALL INTESTINE Annals of Emergency Medicine. Vol. 20, Pg. 208, 1991.
oral-man TDLo 16000 mg/kg KIDNEY, URETER, AND BLADDER: RENAL FUNCTION TESTS DEPRESSED
BEHAVIORAL: COMA Human & Experimental Toxicology. Vol. 9, Pg. 317, 1990.
oral-man TDLo 24000 mg/kg BRAIN AND COVERINGS: RECORDINGS FROM SPECIFIC AREAS OF CNS
SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYE
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Journal of Toxicology, Clinical Toxicology. Vol. 38, Pg. 445, 2000.
intraperitoneal-mouse LD50 5614 mg/kg KIDNEY, URETER, AND BLADDER: CHANGES IN BOTH TUBULES AND GLOMERULI
BLOOD: CHANGES IN SPLEEN
LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA Federation Proceedings, Federation of American Societies for Experimental Biology. Vol. 6, Pg. 342, 1947.
intravenous-mouse LD50 3000 mg/kg Journal of Pharmacology and Experimental Therapeutics. Vol. 65, Pg. 89, 1939.
oral-mouse LD50 5500 mg/kg Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 32(3), Pg. 31, 1967.
unreported-mouse LD50 8050 mg/kg BEHAVIORAL: EXCITEMENT
GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 33(3), Pg. 16, 1968.
unreported-rabbit LD50 5017 mg/kg BEHAVIORAL: EXCITEMENT
GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 33(3), Pg. 16, 1968.
intramuscular-rabbit LDLo 5500 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
BEHAVIORAL: COMA
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Journal of Pharmacology and Experimental Therapeutics. Vol. 41, Pg. 387, 1931.
intraperitoneal-rabbit LDLo 1000 mg/kg Pesticide Chemicals Official Compendium, Association of the American Pesticide Control Officials, Inc., 1966. Vol. -, Pg. 502, 1966.
intravenous-rabbit LDLo 5000 mg/kg BEHAVIORAL: TREMOR
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Journal of Pharmacology and Experimental Therapeutics. Vol. 41, Pg. 387, 1931.
intraperitoneal-rat LD50 5010 mg/kg Kriobiologiya i Kriomeditsina. Cryobiology and Cryomedicine. Vol. 9, Pg. 36, 1981.
intravenous-rat LD50 3260 mg/kg Kriobiologiya i Kriomeditsina. Cryobiology and Cryomedicine. Vol. 9, Pg. 36, 1981.
oral-rat LD50 4700 mg/kg Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 26(6), Pg. 28, 1982.
unreported-rat LD50 13000 mg/kg BEHAVIORAL: EXCITEMENT
GASTROINTESTINAL: NAUSEA OR VOMITING
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Gigiena i Sanitariya. For English translation, see HYSAAV. Vol. 33(3), Pg. 16, 1968.
intramuscular-rat LDLo 3300 mg/kg LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION
BEHAVIORAL: COMA
BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) Journal of Pharmacology and Experimental Therapeutics. Vol. 41, Pg. 387, 1931.
|
| Dermal Toxicity: |
subcutaneous-cat LDLo 2000 mg/kg BEHAVIORAL: MUSCLE WEAKNESS
BLOOD: OTHER CHANGES
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD Archiv fuer Gewerbepathologie und Gewerbehygiene. Vol. 5, Pg. 1, 1933.
subcutaneous-guinea pig LDLo 5000 mg/kg Archives Internationales de Pharmacodynamie et de Therapie. Vol. 51, Pg. 398, 1935.
subcutaneous-mouse LDLo 2700 mg/kg British Journal of Industrial Medicine. Vol. 1, Pg. 207, 1944.
skin-rabbit LD50 9530 uL/kg "Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 731, 1969.
subcutaneous-rat LD50 2800 mg/kg Raw Material Data Handbook, Vol.1: Organic Solvents, 1974. Vol. 1, Pg. 49, 1974.
|
| Inhalation Toxicity: |
inhalation-human TCLo 10000 mg/m3 LUNGS, THORAX, OR RESPIRATION: COUGH
SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE
LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES Archiv fuer Gewerbepathologie und Gewerbehygiene. Vol. 5, Pg. 1, 1933.
inhalation-mouse LC > 200 mg/m3/2H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 25(11), Pg. 57, 1981.
inhalation-rat LC > 200 mg/m3/4H Gigiena Truda i Professional'nye Zabolevaniya. Labor Hygiene and Occupational Diseases. Vol. 25(11), Pg. 57, 1981.
|
Safety in Use Information:
| Category: | humectants, solvents |
| Recommendation for ethylene glycol usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for ethylene glycol flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
| (IUPAC): | Atomic Weights of the Elements 2011 (pdf) |
| Videos: | The Periodic Table of Videos |
| tgsc: | Atomic Weights use for this web site |
| (IUPAC): | Periodic Table of the Elements |
| FDA Indirect Additives used in Food Contact Substances: | View |
| CHEBI: | View |
| CHEMBL: | View |
| Golm Metabolome Database: | Search |
| UM BBD: | Search |
| KEGG (GenomeNet): | C01380 |
| HMDB (The Human Metabolome Database): | Search |
| YMDB (Yeast Metabolome Database): | YMDB01564 |
| Export Tariff Code: | 2905.31.0000 |
| MedlinePlusSupp: | View |
| ChemSpider: | View |
| Wikipedia: | View |
Formulations/Preparations: •emulsifiable glycol ointment base (base g): polyethylene glycol 400 monostearate- 26 g, polyethylene glycol 400- 37 g, polyethylene glycol 4000- 37 g.
•carbowax polyethylene glycol bases- base a: polyethylene glycol 1000- 96%, polyethylene glycol 4000- 4%; base b: polyethylene glycol 1000- 75%, polyethylene glycol 4000- 25%; base c: polyethylene glycol 1540- 70%, polyethylene glycol 6000- 50%. suppository preparation, from table
•carbowax polyethylene glycol bases- base d: polyethylene glycol 6000- 50%, polyethylene glycol 1540- 30%, water and medication- 20%. suppository preparation, from table
•ointment, with cetyl alcohol: polyethylene glycol 4000- 47.5 g, polyethylene glycol 400- 47.5 g, cetyl alcohol, to make 100 g; polyethylene glycol ointment, with sorbitan monopalmitate: polyethylene glycol 4000- 50 g, polyethylene glycol 400- 40 g, sorbitan monopalmitate- 1 g, purified water to make 100 g.
•polyethylene glycol 300 nf; polyethylene glycol 400 usp; polyethylene glycol 1500; polyethylene glycol 1540 nf; polyethylene glycol 4000 usp; polyethylene glycol ointment usp: polyethylene glycol 4000- 40 g, polyethylene glycol, to make 100 g.
•official ointment base is mixture of polyethylene glycol 4000 and 400. this base is water-soluble and non-staining. when a firmer preparation is desired not more than 10% of polyethylene glycol 400 may be replaced by an equal amount of polyethylene glycol 4000.
•available in a broad range of molecular weight grades, i.e., as low as 100,000 to over 5x10+6
|
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| 1,2- | dihydroxyethane | | 1,2- | ethandiol | | | ethane-1,2-diol | | 1,2- | ethanediol | | | ethylene alcohol | | mono | ethylene glycol | | | ethyleneglycol |
Articles:
|